Lung Cancer Cell Lines Inhibit Leukotriene B4 Production by Human Polymorphonuclear Leukocytes at the Level of Phospholipase A2

Masayoshi Abe, Hiroaki Matsuki, Mariko Domae, Hiroshi Kuwata, Ichiro Kudo, Yoichi Nakanishi, Nobuyuki Hara, Takashi Mitsuyama, Tatsuo Furukawa

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We studied cellular interactions between human polymorphonuclear leukocytes (PMN) and lung cancer cell lines by investigating the influence of cancer cells on the production of leukotriene B4 (LTB4) and superoxide anion (O2-) by stimulated PMN. Of the nine cancer cell lines established from human lung cancers that we examined, H23 cells showed the highest LTA4 hydrolase activity. When PMN were stimulated by the calcium ionophore A23187 in the presence of H23 cells, the production of LTB4, 5(S)-hydroxyeicosatetraenoic acid (5-HETE), and 12(S)-hydroxyeicosatetraenoic acid (12-HETE) decreased in a dose-dependent manner. On the contrary, H23 did not inhibit O2 production by PMN. Two other cell lines (N417 and Q9) caused similar inhibition of LTB4 production by PMN. These three cancer cell lines alone did not generate any metabolites of the arachidonic acid (AA) lipoxygenase pathway or any O2 upon stimulation with A23187 alone. The addition of AA dose-dependently reversed the H23-induced inhibition of LTB4, 5-HETE, and 12-HETE production by PMN, suggesting inhibition at the phospholipase A2 (PLA2) level. Furthermore, addition of the cancer cell line Q9 inhibited 14C release from [14C]AA prelabeled PMN in a cell number-dependent manner in the buffer, with and without albumin. The supernatant of H23 cells also inhibited the production of LTB4 by PMN stimulated by A23187, as did the addition of H23 lysate or its 104 × g centrifugation supernatant. While neither the 105 × g supernatant (cytosol) nor the pellet (microsome) exhibited inhibitory activity, the combination of the separated cytosol and microsomal fractions restored the inhibitory activity. Furthermore, addition of the 104 × g supernatant of Q9 lysate to partially purified human cytosolic PLA2 inhibited PLA2 activity in a dose-dependent manner. Our results indicate that the lung cancer cell lines used in our study inhibit LTB4 production by human PMN through inhibition of phospholipase A2 activity, which may contribute to a predisposition to pulmonary infections in patients with lung cancer.

Original languageEnglish
Pages (from-to)565-573
Number of pages9
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume15
Issue number5
DOIs
Publication statusPublished - 1996

Fingerprint

Leukotriene B4
Phospholipases A2
Lung Neoplasms
Neutrophils
Cells
Cell Line
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid
Calcimycin
Arachidonic Acid
Cytosol
Arachidonate Lipoxygenases
Cytosolic Phospholipases A2
Neoplasms
Acids
Centrifugation
Calcium Ionophores
Metabolites
Superoxides
Albumins
Buffers

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Clinical Biochemistry
  • Cell Biology

Cite this

Lung Cancer Cell Lines Inhibit Leukotriene B4 Production by Human Polymorphonuclear Leukocytes at the Level of Phospholipase A2. / Abe, Masayoshi; Matsuki, Hiroaki; Domae, Mariko; Kuwata, Hiroshi; Kudo, Ichiro; Nakanishi, Yoichi; Hara, Nobuyuki; Mitsuyama, Takashi; Furukawa, Tatsuo.

In: American Journal of Respiratory Cell and Molecular Biology, Vol. 15, No. 5, 1996, p. 565-573.

Research output: Contribution to journalArticle

Abe, Masayoshi ; Matsuki, Hiroaki ; Domae, Mariko ; Kuwata, Hiroshi ; Kudo, Ichiro ; Nakanishi, Yoichi ; Hara, Nobuyuki ; Mitsuyama, Takashi ; Furukawa, Tatsuo. / Lung Cancer Cell Lines Inhibit Leukotriene B4 Production by Human Polymorphonuclear Leukocytes at the Level of Phospholipase A2. In: American Journal of Respiratory Cell and Molecular Biology. 1996 ; Vol. 15, No. 5. pp. 565-573.
@article{6062770e621d4fb0a046d26409249c6d,
title = "Lung Cancer Cell Lines Inhibit Leukotriene B4 Production by Human Polymorphonuclear Leukocytes at the Level of Phospholipase A2",
abstract = "We studied cellular interactions between human polymorphonuclear leukocytes (PMN) and lung cancer cell lines by investigating the influence of cancer cells on the production of leukotriene B4 (LTB4) and superoxide anion (O2-) by stimulated PMN. Of the nine cancer cell lines established from human lung cancers that we examined, H23 cells showed the highest LTA4 hydrolase activity. When PMN were stimulated by the calcium ionophore A23187 in the presence of H23 cells, the production of LTB4, 5(S)-hydroxyeicosatetraenoic acid (5-HETE), and 12(S)-hydroxyeicosatetraenoic acid (12-HETE) decreased in a dose-dependent manner. On the contrary, H23 did not inhibit O2 production by PMN. Two other cell lines (N417 and Q9) caused similar inhibition of LTB4 production by PMN. These three cancer cell lines alone did not generate any metabolites of the arachidonic acid (AA) lipoxygenase pathway or any O2 upon stimulation with A23187 alone. The addition of AA dose-dependently reversed the H23-induced inhibition of LTB4, 5-HETE, and 12-HETE production by PMN, suggesting inhibition at the phospholipase A2 (PLA2) level. Furthermore, addition of the cancer cell line Q9 inhibited 14C release from [14C]AA prelabeled PMN in a cell number-dependent manner in the buffer, with and without albumin. The supernatant of H23 cells also inhibited the production of LTB4 by PMN stimulated by A23187, as did the addition of H23 lysate or its 104 × g centrifugation supernatant. While neither the 105 × g supernatant (cytosol) nor the pellet (microsome) exhibited inhibitory activity, the combination of the separated cytosol and microsomal fractions restored the inhibitory activity. Furthermore, addition of the 104 × g supernatant of Q9 lysate to partially purified human cytosolic PLA2 inhibited PLA2 activity in a dose-dependent manner. Our results indicate that the lung cancer cell lines used in our study inhibit LTB4 production by human PMN through inhibition of phospholipase A2 activity, which may contribute to a predisposition to pulmonary infections in patients with lung cancer.",
author = "Masayoshi Abe and Hiroaki Matsuki and Mariko Domae and Hiroshi Kuwata and Ichiro Kudo and Yoichi Nakanishi and Nobuyuki Hara and Takashi Mitsuyama and Tatsuo Furukawa",
year = "1996",
doi = "10.1165/ajrcmb.15.5.8918363",
language = "English",
volume = "15",
pages = "565--573",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "5",

}

TY - JOUR

T1 - Lung Cancer Cell Lines Inhibit Leukotriene B4 Production by Human Polymorphonuclear Leukocytes at the Level of Phospholipase A2

AU - Abe, Masayoshi

AU - Matsuki, Hiroaki

AU - Domae, Mariko

AU - Kuwata, Hiroshi

AU - Kudo, Ichiro

AU - Nakanishi, Yoichi

AU - Hara, Nobuyuki

AU - Mitsuyama, Takashi

AU - Furukawa, Tatsuo

PY - 1996

Y1 - 1996

N2 - We studied cellular interactions between human polymorphonuclear leukocytes (PMN) and lung cancer cell lines by investigating the influence of cancer cells on the production of leukotriene B4 (LTB4) and superoxide anion (O2-) by stimulated PMN. Of the nine cancer cell lines established from human lung cancers that we examined, H23 cells showed the highest LTA4 hydrolase activity. When PMN were stimulated by the calcium ionophore A23187 in the presence of H23 cells, the production of LTB4, 5(S)-hydroxyeicosatetraenoic acid (5-HETE), and 12(S)-hydroxyeicosatetraenoic acid (12-HETE) decreased in a dose-dependent manner. On the contrary, H23 did not inhibit O2 production by PMN. Two other cell lines (N417 and Q9) caused similar inhibition of LTB4 production by PMN. These three cancer cell lines alone did not generate any metabolites of the arachidonic acid (AA) lipoxygenase pathway or any O2 upon stimulation with A23187 alone. The addition of AA dose-dependently reversed the H23-induced inhibition of LTB4, 5-HETE, and 12-HETE production by PMN, suggesting inhibition at the phospholipase A2 (PLA2) level. Furthermore, addition of the cancer cell line Q9 inhibited 14C release from [14C]AA prelabeled PMN in a cell number-dependent manner in the buffer, with and without albumin. The supernatant of H23 cells also inhibited the production of LTB4 by PMN stimulated by A23187, as did the addition of H23 lysate or its 104 × g centrifugation supernatant. While neither the 105 × g supernatant (cytosol) nor the pellet (microsome) exhibited inhibitory activity, the combination of the separated cytosol and microsomal fractions restored the inhibitory activity. Furthermore, addition of the 104 × g supernatant of Q9 lysate to partially purified human cytosolic PLA2 inhibited PLA2 activity in a dose-dependent manner. Our results indicate that the lung cancer cell lines used in our study inhibit LTB4 production by human PMN through inhibition of phospholipase A2 activity, which may contribute to a predisposition to pulmonary infections in patients with lung cancer.

AB - We studied cellular interactions between human polymorphonuclear leukocytes (PMN) and lung cancer cell lines by investigating the influence of cancer cells on the production of leukotriene B4 (LTB4) and superoxide anion (O2-) by stimulated PMN. Of the nine cancer cell lines established from human lung cancers that we examined, H23 cells showed the highest LTA4 hydrolase activity. When PMN were stimulated by the calcium ionophore A23187 in the presence of H23 cells, the production of LTB4, 5(S)-hydroxyeicosatetraenoic acid (5-HETE), and 12(S)-hydroxyeicosatetraenoic acid (12-HETE) decreased in a dose-dependent manner. On the contrary, H23 did not inhibit O2 production by PMN. Two other cell lines (N417 and Q9) caused similar inhibition of LTB4 production by PMN. These three cancer cell lines alone did not generate any metabolites of the arachidonic acid (AA) lipoxygenase pathway or any O2 upon stimulation with A23187 alone. The addition of AA dose-dependently reversed the H23-induced inhibition of LTB4, 5-HETE, and 12-HETE production by PMN, suggesting inhibition at the phospholipase A2 (PLA2) level. Furthermore, addition of the cancer cell line Q9 inhibited 14C release from [14C]AA prelabeled PMN in a cell number-dependent manner in the buffer, with and without albumin. The supernatant of H23 cells also inhibited the production of LTB4 by PMN stimulated by A23187, as did the addition of H23 lysate or its 104 × g centrifugation supernatant. While neither the 105 × g supernatant (cytosol) nor the pellet (microsome) exhibited inhibitory activity, the combination of the separated cytosol and microsomal fractions restored the inhibitory activity. Furthermore, addition of the 104 × g supernatant of Q9 lysate to partially purified human cytosolic PLA2 inhibited PLA2 activity in a dose-dependent manner. Our results indicate that the lung cancer cell lines used in our study inhibit LTB4 production by human PMN through inhibition of phospholipase A2 activity, which may contribute to a predisposition to pulmonary infections in patients with lung cancer.

UR - http://www.scopus.com/inward/record.url?scp=0030292415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030292415&partnerID=8YFLogxK

U2 - 10.1165/ajrcmb.15.5.8918363

DO - 10.1165/ajrcmb.15.5.8918363

M3 - Article

VL - 15

SP - 565

EP - 573

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 5

ER -